MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$11,935,000
EPS
-$0.24
Unit: Dollar

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Royalties and license fees
---0
Total revenues
0 0 0 -
Research and development
6,298,000 5,834,000 3,370,000 3,695,000
General and administrative
7,284,000 7,543,000 6,433,000 13,481,000
Total operating expenses
13,582,000 13,377,000 9,803,000 17,176,000
Loss from operations
-13,582,000 -13,377,000 -9,803,000 -17,176,000
Foreign currency transaction loss (gain)
70,000 131,000 -89,000 119,000
Interest income, net
1,594,000 1,390,000 1,011,000 1,036,000
Other expense, net
-17,000 19,000 -84,000 -123,500*
Loss on extinguishment of liabilities
0 0 --2,500*
Unrealized loss on investment
---0*
Total other income, net
1,647,000 1,540,000 838,000 1,029,000
Net loss
-11,935,000 -11,837,000 -8,965,000 -16,147,000
Unrealized foreign currency translation gain (loss)
--89,000 -
Total other comprehensive income (loss)
--89,000 -
Total comprehensive loss
---8,876,000 -
Net loss attributable to common shareholders
-11,935,000 -11,837,000 --
Basic EPS
-0.24 -0.26 -0.22 -0.446
Diluted EPS
-0.24 -0.26 -0.22 -0.446
Basic Average Shares
49,386,203 45,970,516 41,521,280 36,209,271*
Diluted Average Shares
49,386,203 45,970,516 41,521,280 36,209,271*
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to common...-$11,935,000 Interest income, net$1,594,000 (93.68%↑ Y/Y)Foreign currencytransaction loss (gain)$70,000 (536.36%↑ Y/Y)Net loss-$11,935,000 (-27.59%↓ Y/Y)Total other income,net$1,647,000 (97.48%↑ Y/Y)Other expense, net-$17,000 Loss from operations-$13,582,000 (-33.31%↓ Y/Y)Total operatingexpenses$13,582,000 (33.31%↑ Y/Y)General andadministrative$7,284,000 (73.10%↑ Y/Y)Research and development$6,298,000 (5.32%↑ Y/Y)

Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Inc. (BNTC)